G-CSF and GM-CSF for treating or preventing neonatal infections (Q24248032)

https://api.crossref.org/works/10.1002%2F14651858.CD003066

A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Haemopoietic colony stimulating factors for preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Neutrophil production and function in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Low soluble FcRIII receptor demonstrates reduced neutrophil reserves in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Low-dose vancomycin prophylaxis reduces coagulase-negative staphylococcal bacteraemia in very low birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

The neonatal blood count in health and disease.I. Reference values for neutrophilic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Promising stratagems for reducing the burden of neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003066

Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro

21 January 2018

1 reference

12 December 2020

Neonatal neutropenia in low birthweight premature infants

1 reference

12 December 2020

Neutrophil kinetics in the fetus and neonate

1 reference

12 December 2020

Neutropenia in high-risk neonates

1 reference

12 December 2020

Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor

1 reference

12 December 2020

Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.

1 reference

12 December 2020

Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: A meta-analysis

1 reference

12 December 2020

A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation

1 reference

12 December 2020

Haemopoietic growth factors for neonates: assessing risks and benefits.

1 reference

12 December 2020

A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis

1 reference

12 December 2020

Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants

1 reference

12 December 2020

Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns.

1 reference

12 December 2020

Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis

1 reference

12 December 2020

A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia

1 reference

12 December 2020

Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.

1 reference

12 December 2020

10.1002/14651858.CD003066

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1776900

1776900

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference